Latest Insights

Startup

Raising Funds for Your Start-Up

Stephen Tyrpak, Executive Consultant @ PQE Group speaks about how to raise funds for your start up in the Life Science Industry.

Next Generation Products

New Challenges for Governments: Reduced Risk Tobacco Products alternatives and Tobacco Control Policies

Many countries are working to implement or improve their Tobacco risk reduction policy, to ensure a lower rate of diseases and deaths connected to.

Commissioning & Qualification

ASTM E2500 APPROACH, Process Equipment Suppliers and Qualification SMEs

Zoltan Langosco di Langosco, PQE Group's expert in Validation, explores the ASTM E2500 approach in all of its stages.

Next Generation Products

Reduced-risk products: how do regulators cope with technological developments?

Are Regulatory Authorities ready to face new technologies and products in the Tobacco industry?

Medical Cannabis

Cannabis Products: Last Decades Progresses

Last decade has witnessed an increasing interest in the Cannabis field considering every aspect, from business applications to more scientific and.

Cybersecurity

Cyber Threat to Healthcare and Pharma in times of Covid-19: Strategy vs. Tactical Approach

The convergence of technological platforms and the Covid-19 pandemic is creating an increasingly complex cyber threat landscape.

Cybersecurity

Evolving cyber threats in the Covid-19 era

The COVID-19 Pandemic has shifted business to remote work, contributing to widespread use of less protected devices and inconsistent network.

Annex 1

New EU GMP Vol.4 Annex I and Environmental Monitoring leverage

Learn more about new steps to improve your Enviromental Monitoring plan and where they can lead your cleanroom strategy and contamination control.

Training

Smart People & Digital Learning: an opportunity for companies

Exploring the importance of Human Capital in the Digital Transformation process.

GxP Compliance

How to perform a robust Vaccine Technology Transfer in a challenging era

Vaccine Technology Transfer is a core challenge for pharmaceutical companies that are involved in the fight to Covid-19.